<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> is characterized by arterial or <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, and the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) </plain></SENT>
<SENT sid="1" pm="."><plain>APL are considered to be a cause of an acquired <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable state</z:e> leading to <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> (<z:hpo ids='HP_0002326'>TIA</z:hpo>) </plain></SENT>
<SENT sid="2" pm="."><plain>We examined the causes in 50 young patients with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The most prevalent cause was <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and the incidence of APS was 12.5% </plain></SENT>
<SENT sid="4" pm="."><plain>APL comprise a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of autoantibodies, such as beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I dependent anticardiolipin antibody (beta2-GPIaCL), <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA), and other antiphospholid-protein antibodies </plain></SENT>
<SENT sid="5" pm="."><plain>We examined the incidence and the pathogenic role of antiphospholipid protein antibodies </plain></SENT>
<SENT sid="6" pm="."><plain>The subjects comprised 250 patients (155 male, 95 females) with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, aged 26 to 92 years (mean 72 years) </plain></SENT>
<SENT sid="7" pm="."><plain>We measured beta2-GPI aCL, IgG aCL, LA, phosphatidyserine dependent antiprothrtombin antibody (PS-PT), antiphosphatidyl-serine antibody (PS), antiphosphatidyl-<z:chebi fb="1" ids="24848">inositol</z:chebi> antibody (PI) in each patient </plain></SENT>
<SENT sid="8" pm="."><plain>The incidence of beta2-GPI aCL, IgG aCL, LA, phosphatidyserine, PS-PT, PS, and PI was 2.8%, 12%, 9.2%, 7.2%, 9.6%, and 8.8%, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>The incidence of young <z:hpo ids='HP_0001297'>stroke</z:hpo> patients under 50 years was 5.2% </plain></SENT>
<SENT sid="10" pm="."><plain>Among 13 young <z:hpo ids='HP_0001297'>stroke</z:hpo> patients, 5 had SLE </plain></SENT>
<SENT sid="11" pm="."><plain>Among 23 patients with LA., 18 (78%) patients had PS-PT </plain></SENT>
<SENT sid="12" pm="."><plain>Anti-PS-PT antibody is closely related to LA </plain></SENT>
<SENT sid="13" pm="."><plain>Antinuclear antibody was detected in 79% of the patients with aPS and/or aPI </plain></SENT>
<SENT sid="14" pm="."><plain>We compared the carotid ultrasonographic findings in positive aPI or aPS patients with those in negative ones </plain></SENT>
<SENT sid="15" pm="."><plain>Increased <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>, plaque score and <z:hpo ids='HP_0100546'>carotid stenosis</z:hpo> were more common in aPI and aPS-positive patients than in negative ones Three of 5 patients who showed positive beta2-GPI, aCL and LA, simulataneously, had sysyemic <z:e sem="disease" ids="C0409974" disease_type="Disease or Syndrome" abbrv="">lupus erythematosus</z:e> as an immulological background </plain></SENT>
<SENT sid="16" pm="."><plain>Two of 3 patients with PI and/or PS and beta2-GPI and/or LA were patients with SLE </plain></SENT>
<SENT sid="17" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibody</z:hpo> was considered to be a risk factor of <z:hpo ids='HP_0001297'>stroke</z:hpo>, especially in SLE and/or young female patients </plain></SENT>
<SENT sid="18" pm="."><plain>The incidence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> is more common than beta2-GPI aCL in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="19" pm="."><plain>In SLE patients with <z:hpo ids='HP_0001297'>stroke</z:hpo>, multi-antiphospholipid-protein antibodies was inclined to be present </plain></SENT>
<SENT sid="20" pm="."><plain>LA is closely related to ant-PS-PT and aPI and aPS are associated with anti-nuclear antibody and precipitation of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
</text></document>